TDP-43 pathology is associated with increased tau burdens and seeding.
Sandra O ToméGrigoria TsakaAlicja RoniszSimona OspitalieriKlara GaworLuis Aragão GomesMarkus OttoChristine A F von ArnimPhilip Van DammeLudo Van Den BoschEstifanos GhebremedhinCeleste LaureyssenKristel SleegersRik VandenbergheFrederic RousseauJoost SchymkowitzDietmar Rudolf ThalPublished in: Molecular neurodegeneration (2023)
Our findings extend the current knowledge by supporting a functional synergy between TDP-43 and p-tau. We further demonstrate that TDP-43 pathology worsens p-tau aggregation in an indirect manner and increases its seeding potential, probably by increasing p-tau levels. This may ultimately contribute to tau-driven neurotoxicity and cell death. Because most AD cases present with comorbid LATE-NC, this study has an impact on the understanding of TDP-43 and tau pathogenesis in AD and LATE, which account for the majority of dementia cases worldwide. Moreover, it highlights the need for the development of a biomarker that detects TDP-43 during life, in order to properly stratify AD and LATE patients.